Spots Global Cancer Trial Database for adnexal mass
Every month we try and update this database with for adnexal mass cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Improved Diagnosis of Ovarian Cancer | NCT05842629 | Ovarian Neoplas... Ovarian Cancer Ovarian Cysts Adnexal Mass Adnexal Lesion Adnexal Carcino... Adnexal Neoplas... | - | University of Aarhus | ||
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Improved Diagnosis of Ovarian Cancer | NCT05842629 | Ovarian Neoplas... Ovarian Cancer Ovarian Cysts Adnexal Mass Adnexal Lesion Adnexal Carcino... Adnexal Neoplas... | - | University of Aarhus | ||
| New Biomarkers Evaluating Ovarian Cancer | NCT01466049 | Adnexal Mass | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study | NCT04051502 | Ovarian Cancer Adnexal Mass | Method 1: Indoc... Method 2: Indoc... Method 3: Indoc... Method 3: Indoc... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy | NCT05017246 | Cancer Debulkin... Enlarged Uterus Fibroid Uterus Adnexal Mass | Bupivacaine Morphine Lidocaine | 18 Years - | Washington University School of Medicine | |
| A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants | NCT04487405 | Adnexal Mass | OVAnex | 18 Years - | Aspira Women's Health | |
| The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses | NCT03442881 | Adnexal Mass | Excision of adn... | 15 Years - 70 Years | Cairo University | |
| Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | NCT00987649 | Adnexal Mass Ovarian Cancer | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer | NCT02520115 | Adnexal Mass Borderline Ovar... Ovarian Clear C... Ovarian Endomet... Ovarian Neoplas... Ovarian Serous ... Recurrent Ovari... | Dexamethasone Laboratory Biom... Valproic Acid | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES | NCT05461872 | Adnexal Mass | No intervention | 1 Day - 21 Years | Chinese University of Hong Kong | |
| New Biomarkers Evaluating Ovarian Cancer | NCT01466049 | Adnexal Mass | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses | NCT03442881 | Adnexal Mass | Excision of adn... | 15 Years - 70 Years | Cairo University | |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | NCT05051722 | Endometrial Can... Cervical Cancer Atypical Endome... Cervical Dyspla... Adnexal Mass Ovarian Cancer | Tampon Collecti... Blood Collectio... | 18 Years - | Mayo Clinic | |
| Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | NCT00987649 | Adnexal Mass Ovarian Cancer | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection | NCT04668521 | Adnexal Mass Germline BRCA1 ... Germline BRCA2 ... Hereditary Brea... | OVA360 | 18 Years - | Aspira Women's Health | |
| Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES | NCT05461872 | Adnexal Mass | No intervention | 1 Day - 21 Years | Chinese University of Hong Kong | |
| Preoperative Care In Ovarian Cancer Patients | NCT04260334 | Adnexal Mass Perioperative C... Outcome, Fatal | Preoperative Ed... | 18 Years - | Dokuz Eylul University | |
| Natera Ovarian Cancer Detection Assay | NCT03485651 | Adnexal Mass | 18 Years - | Natera, Inc. | ||
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | NCT05051722 | Endometrial Can... Cervical Cancer Atypical Endome... Cervical Dyspla... Adnexal Mass Ovarian Cancer | Tampon Collecti... Blood Collectio... | 18 Years - | Mayo Clinic | |
| Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test | NCT06366997 | Epithelial Ovar... Adnexal Mass | 18 Years - | Chongqing University Cancer Hospital | ||
| Improved Diagnosis of Ovarian Cancer | NCT05842629 | Ovarian Neoplas... Ovarian Cancer Ovarian Cysts Adnexal Mass Adnexal Lesion Adnexal Carcino... Adnexal Neoplas... | - | University of Aarhus | ||
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
